Vienna, Austria

Johann Jurenitsch

This inventor holds 1 USPTO granted patent. Top assignee: Laevosan-Gesellschaft Gmbh. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johann Jurenitsch. Retrieved from https://idiyas.com/inventor/johann-jurenitsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johann Jurenitsch: Innovator in Pharmaceutical Preparations

Introduction

Johann Jurenitsch is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the area of blocking the attachment of germs to human cells. His innovative work has the potential to impact health care and disease prevention.

Latest Patents

Johann Jurenitsch holds a patent for a pharmaceutical preparation that contains one or several galacturonides as the active substance. This preparation has a degree of polymerization of ≥2 and a degree of esterification of <20%. It is designed to block the attachment of germs to mammalian cells, showcasing his commitment to advancing medical science.

Career Highlights

Jurenitsch is associated with Laevosan-Gesellschaft GmbH, where he continues to develop and refine his inventions. His work in this company highlights his dedication to improving pharmaceutical solutions and addressing critical health challenges.

Collaborations

He has collaborated with notable colleagues, including Andreas De Bettignies-Dutz and Peter Meissner. These partnerships reflect the collaborative spirit of innovation in the pharmaceutical industry.

Conclusion

Johann Jurenitsch's contributions to pharmaceutical preparations demonstrate his innovative spirit and commitment to improving health outcomes. His work is a testament to the importance of research and development in combating diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…